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In the light of the declaration “Nothing about us without us” (Charlton, 2000), interest
in co-production, and coproduced research is expanding. Good work has been done
establishing principles for co-production (Hickey et al., 2018) and for good quality
involvement (Involve, 2013; 4Pi, 2015) and describing how this works in practice inmental
health research (Gillard et al., 2012a,b, 2013). In the published literature, co-production
has worked well in qualitative research projects in which there is often methodological
flexibility. However, to change treatment guidelines in the UK, e.g., the National Institute
for Health and Care Excellence guidelines, and influence service commissioning, high
quality quantitative research is also needed. This type of research is characterized by
formal methodological rules, which pose challenges for the scope of co-production. In
this paper we describe the significant challenges and solutions we adopted to design and
deliver a coproduced randomized controlled trial of mental health peer support. Given
the methodological rigidity of a randomized controlled trial, establishing clearly which
methodological and practical decisions and processes can be coproduced, by whom,
and how, has been vital to our ongoing co-production as the project has progressed and
the team has expanded. Creating and maintaining space for the supported dialogue,
reflection, and culture that co-production requires has been vital. This paper aims to
make our learning accessible to a wide audience of people developing co-production of
knowledge in this field.
Keywords: coproduction, randomized controlled trial (RCT), quantitative research approaches, reflective practice,
methodology and methods of sociological research, peer support (PS)
INTRODUCTION
We discuss co-production in quantitative research (with a specific focus on randomized controlled
trials), how it can work in practice, and the barriers and enablers of co-production. We understand
co-production in research in terms of a knowledge framework. Using standpoint epistemologies
familiar to feminism (Harding, 1991) and other critical disciplines, the active involvement of
people who have made use of healthcare services as researchers, brings a service user knowledge
(Beresford, 2013), or experiential knowledge (Rose, 2017), critiquing and challenging dominant and
universalizing ways of knowing about health, with a primary objective of democratizing research
(Pinfold et al., 2015). This experientially grounded, or tacit knowledge, acquired through private
and personal ways of knowing the mind and body, differs from a more codified or theoretical
knowledge acquired through study and training (Mol and Law, 2004), and offers a competing
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Box 1 | Co-production (Gillard et al., 2012a).
1. High-value research decision-making roles distributed across the
research team.
2. Different interpretations of data within the research team owned and
understood in terms of how who we are has shaped the knowledge we
have produced.
3. Consideration given to whether all members of the team were involved
in the production of knowledge throughout the research project and the
impact of this considered.
4. Methodological flexibility allowed in the research process where scientific
conventions constrains the input of particular team members.
5. Rigorous and critical reflection on why the research was done in the way
it was as integral to the conduct of the research.
6. Research outputs that report critically on how knowledge was produced.
discourse in a healthcare context (Nowotny et al., 2001;Mockford
et al., 2012). A definition of co-production in the context of
multidisciplinary mental health research involving people who
have usedmental health services as members of the research team
is given in Box 1 below.
Roper et al. (2018) outline three core principles of co-
production in the context of mental health research. First
“consumers being partners from the outset” means service users
should be involved in all aspects of the research process from
the beginning and be privy to all information. Professionals
implicitly or explicitly valuing the knowledge of professionals
over lived experience (Scholz et al., 2017), or equating people who
usemental health services with their diagnoses or symptoms,may
hamper their ability to perceive the value in what service users say
(Happell et al., 2015; Kopera et al., 2014). The second principle
states power differentials and tokenism must be “acknowledged,
explored and addressed.” Power differentials exist within the
relationship between professionals and service users and present
a challenge to genuine co-production (McDaid, 2009; Rose et al.,
2010). Whilst is it suggested that co-production helps transform
relationships, co-production can create power sharing risks that
will lead to both parties (professionals and people who use
services) feeling uncomfortable at times. For those with lived
experience, the power differentials can echo disempowering
experiences of using services, resulting in a reluctance to
coproduce (Lwembe et al., 2016). Reluctance to coproduce can
also be experienced by professional researchers. One strong
description of the demands placed on researchers by co-
production is that they are required to renounce their privileged
position as sovereign experts and their monopoly on scientific
knowledge and step down from the proverbial ivory tower of
the academy to enter into dialogue with the world around them
(Phillips, 2009). An exploratory study of Recovery Colleges found
a willingness on the part of the professionals working in mental
health to embrace co-production and relinquish the traditional
power differences (Dalgarno and Oates, 2018). Roper et al. (2018)
third core principle of co-production is the need to encourage
and provide the means for people who use mental health services
to take leadership and develop their capacity within services
and research. In practice, this is difficult to achieve as there are
often insufficient resources to allow full participation, and welfare
benefits can be compromised, acting as a barrier to co-production
(Lambert and Carr, 2018). Scholz et al. (2017) identifies unclear
roles within a structure and a resistance to viewing people who
use services as leaders as barriers to leadership.
Co-production of data analysis needs further development
as this is currently unusual (e.g., Jennings et al., 2018).
There is potential for service user-, clinical-, and academic
researchers to coproduce a richer, integrated analytical narrative
through challenging the previously taken for granted researcher
assumptions and cultural perspectives, producing a more
thorough examination of the data (Tuffrey-Wijne and Butler,
2010). In a qualitative study, additional themes were found
in the data by service user researchers who coded data in
terms of experience and emotions rather than the procedures
and processes typically coded by university researchers (Gillard
et al., 2012b). Despite the difficulties highlighted, studies cited
demonstrate that co-production can work well in qualitative
research projects. There is a relative lack of studies reporting
attempts to co-produce quantitative research, where there are
likely to be additional challenges. We discuss randomized
controlled trial methodology and review the critical literature
in this area before discussing co-production in the context
of randomized controlled trials. Within quantitative research,
a randomized controlled trial (RCT) is considered the “gold
standard” (Barton, 2000) as randomization reduces the risk
of confounding (where the observed effect is due to an
inseparable mix of the treatment effect and other effects).
Randomized controlled trials generally use blinding of treatment
allocation (for researcher) or double blinding (for researcher
and participant) to eliminate bias (in which a belief in the
therapy can also affect the outcome). Efforts are made to
ensure that interactions with the researcher do not have an
effect on the outcome, although the effect of the researcher on
the research process or participants is not usually measured.
Commonly, the researcher attempts to be an impartial observer,
and their emotions are not considered relevant to the research
[i.e., an “objectivist” approach (Ratner, 2002)]. The main
analysis is pre-specified to avoid bias. Research teams can be
hierarchical as particular members of the team provide expert
authority in aspects of the research (e.g., statistical, clinical,
research governance).
Randomized controlled trial methodology has been criticized
for producing misleading results (e.g., poor quality trials produce
inflated treatment effect estimates; Moher et al., 1998). For trials
of complex interventions (in which the treatment contains a
mix of interacting elements, e.g., talking therapies, residential
interventions, social support), appropriate questions go beyond
“does it work” to probe the underlying mechanisms of how, why,
for whom and under what conditions interventions work (MRC,
2008; Blackwood et al., 2010). Randomized controlled trials used
in health research typically fall into the area of “evidence based
medicine,” aiming to mobilizing research to inform healthcare.
However, Greenhalgh et al. (2015), for example, argue that
evidence based medicine may inadvertently devalue the patient
and carer agenda by: (i) limiting patient input into research
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design; (ii) giving low status to individual experience in the
hierarchy of research evidence; (iii) minimizing or ignoring
power imbalances that suppress patient voice; (iv) focusing on
people who seek and can access care thus ignoring those who
do not access services; (v) overlooking the importance of the
patient-clinician relationship; (vi) underestimating the value of
self-management and lay networks of support.
In summary, co-production can deliver research which
incorporates the perspectives of service users and other non-
traditional members of the research team; fundamentally
changing the knowledge production approach, offering social
accountability, and a richer analysis of data, possibly generating
conclusions with more relevance to service users. The challenges
to working meaningfully in this way are substantial, including
tokenism, power differentials, the need for emotional, and
practical support for service users. Randomized controlled trials
are a powerful tool for finding out “what works” in mental
health services, yet the methodology has been criticized in a
number of ways, including unrealistic expectations that the
research process itself has no effect while suppressing knowledge
from lived experience. These criticisms suggest co-production
might improve, rather than weaken the randomized controlled
trial methodology. For example, some of the challenges in trials
(especially of complex interventions with a social component)
might be usefully addressed by integrating other types of
expertise—including patient and carer insight—into the research
process. We identified no prior publications exploring these
potentials in a randomized controlled trial. To address this, this
paper reports the possibilities and challenges of coproducing a
randomized controlled trial.
Setting
The setting for the research is multisite randomized controlled
trial of peer support for discharge from inpatient to community
mental health services in the UK (Gillard and Marks, 2016). The
trial aimed to recruit 590 participants, randomized 50:50 to peer
support and care as usual. The trial hypothesized that participants
receiving peer support would be less likely to be readmitted
to inpatient psychiatric care in the year post-discharge than
participants receiving care as usual. Peer support was provided
individually by peer workers—people with previous experiences
of using mental health services—selected and trained to provide
peer support for the discharge transition and supervised by an
experienced peer worker. We note that peer workers did not
occupy any other roles within the project (e.g., they were not
also researchers).
Research Team
The research was undertaken by a research team that included
a Chief Investigator (a health services researcher), four clinical
academics (a psychiatrist, two psychiatric nurses and a clinical
psychologist), three statisticians, a health economist, a health
psychologist, two managers of peer support services (one
working in the NHS and one in the not-for-profit sector),
an experienced peer worker (working in the NHS) and two
experienced service user researchers. A trial manager who also
brought experience of having used mental health services, and
a total of nine further service user researchers joined the team
to undertake recruitment of participants and data collection. The
aimwas to coproduce throughout the study, using the framework
cited above as a starting point (Gillard et al., 2012a), with all
members of the research team involved in the initial conception
of the research and the extended team (including trial manager
and all service user researchers) involved in decisions made about
conducting the trial (i.e., how to put the trial protocol into action)
once the research programme was underway.
METHOD
Two methods were used to explore co-production in the trial.
First, members of the team co-authoring the paper selected
examples of decision-making about the design of the trial. We
select examples which, to a greater and lesser degree, include
a range of members of the research team, and service user
researchers working on the trial in the decision-making process
(i.e., where there was more or less co-production involved). We
illustrate the decision-making process by citing directly from
minutes of the different meetings that collectively, manage the
trial. These include: the Trial Management Group (TMG—a
subgroup of people involved in managing the trial who meet
on a monthly basis including Chief Investigator, Senior Trial
Statistician, Trial Manager, one of the two experienced service
user researchers, Health Economist, the academic psychiatrist
plus a data management and a quality assurance advisor); the
Lived Experience Advisory Panel (LEAP—a group of people
independent from the trial who have personal experience of peer
support, using mental health services and working as service user
researchers who meet biannually to advise on conduct of the trial
from a lived experience perspective); and investigator meetings
(large biannual meetings where the whole research team come
together). We reviewed those minutes to identify how, when
and why the decisions which shaped the scope and focus of the
research were reached and the potential impact of those decisions
on the research process and outputs (extracts of these are quoted
and labeled as “minutes” in the text below).
Second, members of the team who were involved in
either making those decisions or implementing them into
practice wrote reflections on the decision-making process and
consequences (extracts of these are labeled “reflections” where
quoted below). Drawing on a sequential method of analysis
(Simons et al., 2008), accounts of these meetings and our
reflections were iteratively co-edited by the authors as this paper
was written. In this sense our shared writing and re-writing was
an integral part of our method of enquiry (Richardson, 2000;
Simons et al., 2008).
FINDINGS
We present three key decisions at which co-production was
most challenged and/or most productive. We focus on these
to illustrate the different perspectives and how these were
discussed and resolved.We then reflect on the implications of the
decisionsmade. These decisions relate to: (i) Identification of trial
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population; (ii) Choice of psychometric measures and outcomes;
(iii) Development of the trial statistical analysis plan.
Trial Population
Defining the eligibility criteria potential participants must meet
to join the study is an important decision as it determines the
group of people to whom trial results may be generalized. There
was a structured discussion at the first investigator meeting about
targeting the peer support intervention. The chief investigator
leading the meeting used a graphic to launch the discussion
in which the central zone refers to the ideal targeting of the
intervention as an intersection of (1) people most likely to benefit
(i.e., where need is highest), (2) existing evidence about what
is most likely to work best, (3) what is known about how peer
support works (the change mechanism). Figure 1 is a smarter
version of the original graphic used in the meeting.
Concern was expressed by clinical academics around the
table that if the trial showed a very weak or not statistically
significant effect of peer support because we had not chosen the
trial population carefully enough then we would do a disservice
to peer support services (as these might be less likely to be
commissioned going forward). Minutes from the meeting show
that concern was raised that:
A negative result would have the potential to undermine peer
support work as it is. (minutes)
Members of the team with lots of experience working on
randomized controlled trials argued that a discrete rather than
heterogeneous diagnostic population be chosen to ensure the
methodological quality and subsequent impact of the trial on
treatment guidelines:
The trial is not powered for subgroup analysis and if the result
turns out to be negative then it will not be recognised in
FIGURE 1 | Graphic to aid discussion about the trial population.
the international community nor adopted by guidelines . . . a
specific population [should be] chosen, for example psychosis, for
inclusion criteria. (minutes)
The two service user researchers on the team at that time and
other members of the team involved in delivering peer support
argued strongly against restricting inclusion by diagnosis on the
grounds that peer support was not usually provided like this in
practice and that the connections peers made were generally not
on the basis of shared diagnosis. Minutes from the discussion
record the following comment:
The essence of peer support must not be compromised and the
peer support service developed and tested for the research must
be one that is workable and justifiable to inpatient peers and peer
workers in practice. Reasons for peer support being offered to
one person over another have to be credible in the real world.
Peer worker and peer support leader members of our team must
be included in this design decision, it can’t be made simply for
research trial success purposes. We have not set out to design
a diagnosis specific peer support service, we have set out to
offer people support with discharge from inpatient to psychiatric
care. Diagnoses can shift with each progressive encounter with
secondary care and are culturally bound and are imposed and
often not owned by the service users or peers themselves. We
should be asking who the peer support would be most useful
to. (minutes)
In later discussions about how a suitable population might
be identified, clinical academics responding by suggesting an
approach based on known predictors of our primary outcome
(psychiatric readmission within 1 year of discharge):
. . . identifying people most likely to be readmitted, using numbers
of readmissions as a predictor. (minutes)
It was agreed by the team that this approach would satisfy
both the need for a discrete population that findings could
be generalized to (ensuring methodological quality) while also
retaining the integrity of peer support (by not defining peer
relationships by diagnostic categories). A plan was put in
place to approach trial sites for data about their inpatient
populations so that a final decision could be made on
eligibility criteria that would also enable us to feasibly deliver
recruitment targets.
Reflections About the Trial Population
Three service user researchers who co-authored the paper
reflected on their experience of applying the eligibility criteria
in practice. It was noted that not using diagnosis as the main
eligibility criteria supported researchers in working from a
service user researcher perspective:
The non-diagnostic approach to recruitment fits well with the
service user researcher approach to recruitment (e.g., being
alongside someone as they considered whether to join the study,
and communicating what peer support is). Overall, this has been
a positive way of working - the reduced focus on diagnosis felt less
discriminatory, medicalised, or pathologising.We appreciated the
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fact that it doesn’t disclose to other service users on the ward the
diagnosis of our participants or potential participants. (reflection)
The text above demonstrates a good amount of agreement
between the perspectives of the service user researchers and
the perspectives of others with lived experience who had been
involved in the study at the time when this decision was made.
In this example, although this was a decision that was taken
before many of the service user researchers joined the project, the
coproduced decision fitted well with the service user researchers’
feelings about the “ethos” of the project.
Trial Psychometric Measures
and Outcomes
All trials define in advance a primary outcome used as the main
measure to determine whether the intervention had an effect.
The primary outcome is also used to calculate the necessary
sample size for the trial. In addition, it is common to select a
number of secondary outcomes, for which it is expected that
the intervention will also have an effect. The primary outcome
for this trial—psychiatric readmission within 12 months of
discharge—had been suggested by the research funder, at review
of the funding application, as an example a concrete indicator of
patient benefit they would expect as the primary outcome of the
trial. As such we note an absence of wider co-production across
the team about the selection of the primary outcome.
The secondary outcomes were selected at two meetings as
part of the development of the proposal. The meetings included
academics and clinicians involved in evaluating peer support
and conducting trials, as well as people with experience of
developing, delivering and evaluating peer support services
from a lived experience perspective. These discussions were
informed by a peer support change model developed by the
team based on previous qualitative research (Gillard et al.,
2017), which had been coproduced by service user researchers,
peer workers, clinicians and researchers. The change model
suggested that peer support had an effect on hope, experience
and anticipation of stigma, strength of therapeutic relationship
and social connectivity.
There was no measure of clinical severity in the original
proposal but a measure of clinical severity—the Brief Psychiatric
Rating Scale (Overall and Gorham, 1962)—was added as a
secondary outcome as a direct consequence of the decision
not to define the population by diagnosis. This decision was
taken by the chief investigator on the advice of members of the
Trial Management Group with experience running randomized
controlled trials in order to be able to describe, clinically, an
otherwise diagnostically heterogeneous population. This was
done largely so that the trial would meet peer review expectations
for inclusion in high impact journals and systematic reviews,
as well as to enable comparison with other peer support
trials. The minutes of several meetings of the Lived Experience
Advisory Panel document the reactions of members of the
team to implementing this decision. There was an extended
discussion about the use of the Brief Psychiatric Rating Scale at
a Lived Experience Advisory Panel meeting held shortly after
recruitment to the pilot trial began. It was noted that:
The service user researcher team have been arguing against doing
it since this came to light as they started preparation for the data
collection part of their role . . . the solution has been for service
user researchers to decide how they will do this measure, do it
openly, change some of the language of the tool and explain that
they are rating it on the basis of conversation with the service
users they are interviewing ‘peering through the psychiatric lens
together’. (minutes)
And that:
The concerns service user researchers raised included using the
wrong measure for peer support - clinical symptom change is
not a particular aim of peer support; the potential for distress
to service user researcher or participant due to similarity with
previous experiences of psychiatric assessment, non-service user
researcher/service user friendly language and administration,
challenge to service user researcher role - service user researchers
employed for lived experience perspective being asked and trained
to take a psychiatric perspective. (minutes)
However it was also noted by the Lived Experience Advisory
Panel that:
Co-production is maybe about being willing to keep going
together and not “strutting out” when things don’t fit with our
ideas. (minutes)
Nonetheless, Lived Experience Advisory Panel meeting notes
report the need for caution in interpreting the data produced by
Brief Psychiatric Rating Scale:
We need to take care in our interpretation of the Brief
Psychiatric Rating Scale data. Since if peer support goes well
service users could be more open to sharing difficulties with the
service user researcher at the second assessment; this could be
(mis)interpreted as peer support making people worse. (minutes)
There was some discussion of the way in which delivery of the
Brief Psychiatric Rating Scale had been adapted by the service
user researchers:
The Brief Psychiatric Rating Scale would have damaged rapport if
it had come anywhere but the end of the interview but service
user researchers are happy with the way they have been able
to make it more person friendly and be open about what it is.
[Only] one participant so far shut down the interview at this
point (i.e., when the Brief Psychiatric Rating Scale questions were
asked). (minutes)
As a result of these discussions changes were made
to the trial database to enable service user researchers
to omit the Brief Psychiatric Rating Scale if it wasn’t
completed due to, for example, objections or distress from
the participant.
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Reflections About the Trial Psychometric Measures
and Outcomes
Service user researchers who were co-authors of this paper
reflected on the decision to include the Brief Psychiatric Rating
Scale as an outcome measure. These reflections tell us about how
co-production works in practice with respect to the consequences
of the decision to include this very clinical measure. One
described the initial plan of how to conduct this part of the
interview as follows:
In practice, using the Brief Psychiatric Rating Scale means being
transparent with service users; we are able to be honest about the
very psychiatric approach of the Brief Psychiatric Rating Scale
which does not necessarily fit with many aspects of the ethos of
the project. (reflection)
This means taking a stance toward the measure which makes
it clear that we wouldn’t use this type of medical approach to
understanding psychological distress as a first preference. Co-
author service user researchers reflect that, despite approaching
the issue as described above, it can still be difficult to conduct
this assessment:
We often spend a lot of time building rapport with a participant,
talking about lived experience, and working hard to create a safe,
supportive environment, attempting to equalise inequalities in
power. Using such a psychiatric measure abruptly changed the
dynamics we had worked hard to create with the participant
causing a sense of unease due to appearing contrary to the
principles of survivor research, and can be uncomfortable to
conduct from a service user perspective. This becomes even more
difficult at follow up. At follow up, the Brief Psychiatric Rating
Scale has to be scored in the middle of the interview to prevent
scoring whilst un-blinded which means completing it in front of
participants. (reflection)
Beyond the way that the rating scale affects the interviews with
participants, there are additional issues with the use of the scale,
as outlined in the following reflection:
The Brief Psychiatric Rating Scale is quite skewed toward
psychotic type symptoms. Consequently, we have often felt
the measure does not reflect the state of someone’s emotional
wellbeing accurately as, for example, there are only two or three
places in which trauma or suicidality may affect the score. We
have quite lengthy discussions with service users, sometimes
spending 3 hours with each person, and it seems reductive
to then use a number score on the Brief Psychiatric Rating
Scale as this does not wholly capture the wealth of information
communicated. (reflection)
The above statement communicates a frustration that can often
be felt by researchers with a qualitative interest when they
conduct semi-structured interviews which are used to generate
numerical scores in quantitative research. The statement again
reflects that this way of summarizing the trial population does not
sit easily withmany of the service user researchers, and would not
be their first choice of method. The reflections continue:
Most of the service user researchers were not involved in the
decisionmaking process around using the Brief Psychiatric Rating
Scale as we were not in post then, meaning there has been a lack
of opportunity to coproduce in this area. This issue is aggravated
as the research is a randomized controlled trial, for which the
protocol needs to be fixed early on in the project. It is not
possible to adapt many things as time goes on, unlike with our
qualitative interview schedules which have been reworked and
adapted after the pilot quite significantly, and have afforded plenty
of opportunity to coproduce. (reflection)
This scenario, in which research decisions are coproduced, but
many of the team of service user researchers did not have the
opportunity to be involved in that co-production, seems likely
to be commonly experienced in the context of randomized
controlled trials. This is because these decisions are made well
in advance of the start of data collection. The fact that the service
user researcher jobs are advertised as working on a coproduced
project can therefore raise unrealistic expectations of influencing
key decisions. The chief investigator of the trial also reflected on
the decision around including a clinical measure, illustrating how
tension might remain long after a decision is taken:
I had misgivings about using Brief Psychiatric Rating Scale in
the trial. All our other research has suggested that peer support
works socially, it’s about relationships and connections, rather
than clinically. We didn’t expect peer support to have an impact
on clinical outcomes when we were developing the study, and
that is also what the literature tells us. I knew that there would
be a tension between the very clinical nature of the measure and
the values underpinning peer support and service user research.
However I could see the rationale for using a clinical measure
to describe the trial population so that we would be able to
say, if the peer support works, who it works for. We know
that people are discharged from hospital when they are more
or less well depending on very transient things like demand for
beds and variations in how services are set up locally, so we
did need something else here or it would be difficult for people
to draw any conclusions about how relevant any findings from
ENRICH would be in different parts of the UK or in different
countries. (reflection)
In the following text, reflections about alternatives to the Brief
Psychiatric Rating Scale, alongside alternative ways that this part
of the project could have unfolded are explored:
Perhaps including a clinical measure was an executive decision
I would have always felt I needed to make but there were
consequences of not including the wider team, and especially
service user researchers in that decision. First, we might
have identified a different measure that could have been less
challenging to use, whichmight have addressedmany of the issues
raised by the (service user researcher) team, issues that they had to
work with on a daily basis. Second, had people felt involved in the
decision, even if they had disagreed with it, then the subsequent
discussion around how to implement Brief Psychiatric Rating
Scale might have felt more collaborative and have been more
productive of valuable learning about how best to measure things
like ‘severity’. And finally, all our discussions were tinged by the
decision having been already made, and then guillotined anyway
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as we needed to register the trial, which wasn’t good for our sense
of working co-productively as a team. (reflection)
The text above demonstrates the difficulty of coproducing
whilst using a research method for which many things need
to be specified in advance. The importance of planning
plenty of time to coproduce at the stages of the project in
which key decisions are made are highlighted, alongside
the difficulty of trying to coproduce with people who
were not on the project at a time when key decisions
were made.
Trial Statistical Analysis Plan
It is best practice in a trial to publish a statistical analysis
plan demonstrating that analyses have been specified before
outcomes data have been viewed (rather than analyses
conducted to fit the data). The primary analysis was specified
in the protocol, but additional analyses where the wider
team might have meaningful input, included identification
of groups for any subgroup analysis and specification
of the Complier Average Causal Effect (CACE) analysis
(see below).
Primary trial analyses examine “intention to treat”; i.e., all
participants randomized to receive the intervention—whether
they took up the offer or not—are compared with all participants
randomized to care as usual (White et al., 2011). This is
because people do not always take up treatment offers. We can
additionally examine the effect of treatment receipt using a CACE
analysis. A definition of what constitutes having received the
intervention is needed; a minimum level of engagement with the
intervention, below which participants can be assumed to have
had no benefit. Subgroup analyses explore whether there was any
difference in effect of the intervention for different groups of
participants (e.g., men and women).
These analyses were initially discussed at meetings of the
investigator team and the Trial Management Group where it
was decided that the input of the Lived Experience Advisory
Panel and service user researcher team was needed to inform
these decisions. One of the trial statisticians held workshops with
the Lived Experience Advisory Panel and service user researcher
team; co-facilitated by the chief investigator. These meetings
introduced and explained the statistical analysis plan as a whole,
indicating where and why certain analyses had already been
decided, and where there was scope for more co-production.
Within the service user researcher team, two members had
particularly valuable prior experience for this discussion, one
from working in epidemiology and one from PhD research with
a high degree of statistical content.
Discussions on the CACE analysis included “how many
contacts” between participant and peer worker were enough
to benefit from the intervention; the statistician and chief
investigator suggested a single contact is potentially beneficial.
However, notes from the service user researchermeeting indicate,
based on their experiences of working on the trial, that:
First session with peer worker often focuses around logistical
aspects of relationship and if this is the only session to
occur it is unlikely that therapeutic benefit will have been
delivered. (minutes)
Furthermore, service user researchers reminded the meeting
of the importance of choice in developing peer support
relationships, suggesting that:
A session in the community indicates that the participant has
chosen to engage with the peer worker. Whilst in hospital
participant may be visited by peer worker without them actively
deciding to engage. (minutes)
From these discussions it was decided that the threshold
for receipt of intervention for the CACE analysis is at least
two contacts with peer worker, at least one of which should
be in the community post-discharge. The discussions with
both Lived Experience Advisory Panel and service user
researcher team about potential subgroup analyses were
wide-ranging. The statistician suggested to both meetings
that we consider either a single subgroup analysis of a
small number of study outcomes, or a small number of
subgroup analyses of just the primary outcome. Both Lived
Experience Advisory Panel and service user researchers
felt that the latter option would be more useful as their
experiences of involvement in and researching peer support
suggested that there were a number of meaningful relationships
between group identity and the way in which peer support
might work.
The draft plan prepared by the statistician included broad
diagnostic groups (psychotic disorders, personality disorders,
and other non-psychotic disorders) as potential subgroups. The
service user researchers had reservations about this due to the
transitory nature of many participants’ diagnoses and because
they felt diagnoses did not always match the way participants
described their own experiences:
Participants may have other diagnoses or may have a primary
diagnosis that is not the cause of the current admission. We
collect other data on medical history via self-report. This data
may be challenging to use, it is collected as free text, includes
diagnosis as described by participants that might not use standard
terminology. (minutes)
The chief investigator argued in favor of keeping broad diagnostic
category in the analysis because, irrespective of the validity of
a diagnosis, people receive different treatment depending on
their diagnosis which may interact with their experiences of
peer support. Thus, diagnostic group was retained as a subgroup
with the qualification that we would interpret any findings in
relation to people’s experiences of using different mental health
services, rather than evidence that “peer support worked for some
diagnoses, but not for others.”
Finally the Lived Experience Advisory Panel suggested that
the mechanisms of peer support are in large part social—
enabling people to connect to community—and so might work
differentially in people who were already well connected socially
compared to people who were isolated in the community, a
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suggestion which was well received and has been adopted to
define suitable subgroups.
Reflections on Developing the Trial Statistical
Analysis Plan
The statistician who led the workshops on the statistical analysis
plan reflected on the involvement of service user researchers and
the Lived Experience Advisory Panel in developing elements of
the plan.
The input from service user researchers and the Lived Experience
Advisory Panel was vital in deciding what assumptions were
reasonable to make in carrying out this analysis. The decision
to carry out an analysis using a binary cut off as to whether
treatment was received did not address all the questions the
service user researchers and Lived Experience Advisory Panel
would have liked to ask. Other questions considered included
what the effect would be of receiving only one session, or in
response to different numbers of sessions. As a statistician I
felt that I needed to guide the group away from more complex
questions as I felt that limitations imposed by the study design
and methods available would not allow us to get good answers to
these questions. (reflection)
Service user researchers working on the project were positive and
enthusiastic about their input into the statistical analysis plan and
felt that co-production had worked really well in this area, as the
following text demonstrates:
I felt that, from the start, the statisticians on the project were
really interested in, and supportive of, incorporating ideas from
members of the team with lived experience into the analysis plan.
Co-production felt really well planned, smooth and organized.
We had the opportunity to ask all the questions we’d like to about
the plan, which were answered in full. Our suggestions were really
well received and had a big impact on the plan. Co-production
worked really well for all parties involved. (reflection)
In the above texts, the practice of combining statistical knowledge
with clinical knowledge (from clinicians or those with lived
experience), to inform the statistical methods used and the way
those methods are applied is illustrated. Statisticians specializing
in analysis of randomized controlled trials always work in
interdisciplinary teams, drawing on the knowledge of others in
the team to develop the statistical plan. Perhaps for this reason,
developing a coproduced trial statistical analysis plan was one of
the easier areas in which to coproduce the research.
DISCUSSION
This paper set out to explore the possibilities and challenges
of coproducing randomized controlled trials, focussing on a
randomized controlled trial of a peer support intervention in
mental health which explicitly set out to coproduce knowledge
and employed service user researchers. We illustrated this
through examples of where co-production seemed to go well
and where it was challenging, covering the three key areas
of: identifying our trial population, creating a trial statistical
analysis plan and selecting psychometric outcome measures.
The decision around identifying our trial population involved a
wide range of team members who also very explicitly identified
the perspectives they were working from, as clinical academics,
trialists, and service user researchers, and how that informed
the views they brought to the discussion. The importance of
not just including different perspectives, but of being explicit
about those perspectives has been identified as key to the co-
production of knowledge (Gillard et al., 2012a) and indicative
of the social accountability of the knowledge production process
(Nowotny et al., 2001). As such, we did not find that the
knowledge of our research professionals was valued over the
experiential knowledge of other team members (see also Scholz
et al., 2017). The service user researchers’ lived experience
was valued as primary expertise on peer support and as such
contributed in equal measure to our final decision about the
trial population, alongside methodological insight. Service user
researchers and team members involved in peer support took
on a leadership role in advocating forcefully, at the outset of
the project, that the essence of peer support not be undermined
by the study design. Roper et al. (2018) indicate that having
the means to take a leadership role in this way, especially for
non-conventional research team members, characterizes non-
tokenistic peer support. The initial research team meeting began
with a discussion about research co-production, and team
members were invited to describe in some length their role in
the research and what they felt their priorities for the project
were. Perhaps this approach, alongside the fact that nearly half
the members of the research team were working from a lived
experience perspective, enabled people to take on this leadership
role. In this respect, at this stage of the project, co-production had
been sufficiently resourced (Lambert and Carr, 2018).
As evidenced in the discussions around the statistical analysis
plan and in the reflections of the statistician, we neither found
that lived experience was devalued as a source of knowledge
(Scholz et al., 2017), nor did we encounter reservations about the
abilities of service user researchers to hold educated positions on
the technical issues raised by the plan that have been cautioned
against elsewhere as a barrier to co-production (Happell et al.,
2015). Perhaps that was a reflection of the research literacy and
expertise of our team. However, as identified by Roper et al.
(2018), we did see open acknowledgment of power differentials
that existed in the team in this phase of the study. The statistician
was, in effect, the arbiter of what potential changes could be made
to the plan, and made it very clear at the outset of both meetings
where aspects of the analysis had already been determined—and
why, methodologically, that needed to be the case—and where
there remained meaningful opportunities for the analysis process
to be shaped. This approach was appreciated in feedback from
both the Lived Experience Advisory Panel and members of the
service user researcher team.
We note how the co-production of decisions around trial
population and statistical analysis plan had been made possible
by the retention of a certain amount of flexibility in the
research process. As regards selecting psychometric outcome
measures, this flexibility was absent from the decision about
including the Brief Psychiatric Rating Scale—it was presented as
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a fait accompli—and so limited opportunity for co-production.
It is clear from the discussions referred to above that the
team worked hard to address the challenges raised by the
inclusion of the Brief Psychiatric Rating Scale but these efforts
were imposed on the team post-hoc, rather than engaged
in from the outset as a collaborative endeavor. In these
circumstances co-production could be described as tokenistic,
limited by the power imbalance in the team that flowed
from that executive decision (Rose et al., 2010), especially for
those service user researchers who came later to the team.
Indeed wider members of the team had not been privy at
all to that particular decision (Roper et al., 2018) and it
is possible that the undermining of trust in the research-
participant relationship that is referred to in the service user
researcher reflections mirrors a damage to trust in the team at
this point.
IMPLICATIONS
On balance we reflect that it is possible to incorporate a co-
production approach to research—as defined in Box 1 above—
into a randomized controlled trial, especially with respect to the
role of service user researchers in the research team. However,
we also note that there are multiple challenges that need to
be addressed to optimize co-production across all aspects of
the project. Clarity around which aspects of decisions can be
coproduced is essential, as is clear communication of the knock-
on implications of any decision for the rest of the project.
Our findings suggested that, in a randomized controlled trial,
the methodology demands that co-production is front-loaded
wherever possible as it could be challenging for service user
researcher members of the team to implement some research
decisions into practice where they had not been involved
in early decision-making. This means most of the time for
co-production must be scheduled toward the start of the
project. However, we also found that co-production of the trial
analysis strategy worked well within circumscribed and well-
communicated limits.
RECOMMENDATIONS
Scheduling time to co-produce decisions and recognize that
much of this needs to be done at the planning (grant application)
stages and early in the trial is recommended. It is likely that
researchers will find that co-production occurs more or less
completely in different areas of the project. We recommend
reflecting on and documenting this to build the literature of the
barriers and enablers of co-production in randomized controlled
trials so that all interested parties can develop their skills and plan
to coproduce research. Co-production of the analysis strategy,
with clear explanations of the implications of the questions
and the scope for co-production is recommended and can be
very successful.
The expectations for influencing the methodology of the
research in co-production can be high for all parties. Many
contrasting views can be presented and not all these views can
always be incorporated into the research. Team members can
be very committed to the positions they bring to the research
and expectations are not always met. We recommend regular
reflection on the impact of co-production to support emotional
well-being, morale and team cohesion.
Power differentials are always present in teams but creating an
environment in which they can be honestly acknowledged and
challenged when discussing co-production enables those in less
powerful positions to have an impact on high value decision-
making. Co-production adds time to a research project, which
must be costed appropriately. Co-production in some aspects
of a large research project, despite best intentions, may become
tokenistic if those conditions are not met. Co-producing can be
considered to be an additional variable when assessing quality of
research (Sweeney et al., 2019).
STRENGTHS AND LIMITATIONS
The study is limited by the constraints imposed by our approach
to capturing and analyzing data about the research process.
We rely on minutes from team meetings and the written first
person reflections of team members as our case study data. Not
all co-production takes place in team meetings and neither is
co-production confined to decision making, while minutes and
reflections do not necessarily include the views and experiences
of all team members (arguably our data is somewhat selective).
An ethnographic approach to exploring co-production and
the randomized controlled trial, comprising observations and
interviews conducted by a researcher who was not a team
member might have offered a more comprehensive data set and
a more systematic approach to analysis. However, as an initial
exploration our approach offered feasibility. A focus on decision
making, critical reflection on the inclusion of the diversity of
voices in the team in those decisions, and consideration of
the implementation of those decisions into practice does offer
meaningful insight into key aspects of co-production (Gillard
et al., 2012a). We were careful to select a range of positive
and challenging experiences of research decision making and
our findings were given external validity by our reading of the
co-production literature.
CONCLUSIONS
Co-production challenges and potentially changes aspects of
randomized controlled trial methodology through the inclusion
of a wider range of voices in the research-decision making
process, including non-traditional expertise such as the lived
experience of people who have used mental health services.
Through balancing all the factors relevant for a decision,
contributed by all the experts (methodological, clinical, and
experts by experience), randomized controlled trials can be
conducted in a way which incorporates and values service
user perspectives, delivering research with greater social
accountability which is also hopefully of higher quality and more
relevant to service users and their mental health journeys.
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